Uridine 5''-?(2-?Methylpropanoate) can be used in the preparation of molnupiravir ((EIDD-2801) (CAT# E985795), which is an antiviral agent that is under development for the treatment of COVID-?19 and has promising activity against the SARS-?CoV-?2 virus.